OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1∗05 Carriage Is Associated With Antidrug Antibody Formation in Patients With Inflammatory Bowel Disease
Elizabeth Spencer, Jordan Stachelski, Thierry Dervieux, et al.
Gastroenterology (2022) Vol. 162, Iss. 6, pp. 1746-1748.e3
Closed Access | Times Cited: 39
Elizabeth Spencer, Jordan Stachelski, Thierry Dervieux, et al.
Gastroenterology (2022) Vol. 162, Iss. 6, pp. 1746-1748.e3
Closed Access | Times Cited: 39
Showing 26-50 of 39 citing articles:
Challenges in IBD Research 2024: Pragmatic Clinical Research
Jessica R. Allegretti, Liliana Bordeianou, Oriana M. Damas, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. Supplement_2, pp. S55-S66
Open Access | Times Cited: 1
Jessica R. Allegretti, Liliana Bordeianou, Oriana M. Damas, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. Supplement_2, pp. S55-S66
Open Access | Times Cited: 1
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis
Francisco Rodríguez‐Moranta, Federico Argüelles‐Arias, Joaquín Hinojosa del Val, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 5, pp. 522-552
Open Access | Times Cited: 1
Francisco Rodríguez‐Moranta, Federico Argüelles‐Arias, Joaquín Hinojosa del Val, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 5, pp. 522-552
Open Access | Times Cited: 1
HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn’s Disease
Jeremy Adler, Joseph A. Galanko, Rana Ammoury, et al.
The American Journal of Gastroenterology (2024) Vol. 120, Iss. 5, pp. 1076-1086
Closed Access | Times Cited: 1
Jeremy Adler, Joseph A. Galanko, Rana Ammoury, et al.
The American Journal of Gastroenterology (2024) Vol. 120, Iss. 5, pp. 1076-1086
Closed Access | Times Cited: 1
Biomarkers That Predict Crohn’s Disease Outcomes
Pablo A. Olivera, Mark S. Silverberg
Journal of the Canadian Association of Gastroenterology (2023) Vol. 7, Iss. 1, pp. 59-67
Open Access | Times Cited: 3
Pablo A. Olivera, Mark S. Silverberg
Journal of the Canadian Association of Gastroenterology (2023) Vol. 7, Iss. 1, pp. 59-67
Open Access | Times Cited: 3
The Combination of Predictive Factors of Pharmacokinetic Origin Associates with Enhanced Disease Control during Treatment of Pediatric Crohn’s Disease with Infliximab
Marla C. Dubinsky, Shervin Rabizadeh, John C. Panetta, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2408-2408
Open Access | Times Cited: 3
Marla C. Dubinsky, Shervin Rabizadeh, John C. Panetta, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2408-2408
Open Access | Times Cited: 3
Terapia personalizada en la enfermedad inflamatoria intestinal
Paula Calderón, Paulina Núñez, Pilar Nos, et al.
Gastroenterología y Hepatología (2023) Vol. 47, Iss. 7, pp. 763-770
Closed Access | Times Cited: 3
Paula Calderón, Paulina Núñez, Pilar Nos, et al.
Gastroenterología y Hepatología (2023) Vol. 47, Iss. 7, pp. 763-770
Closed Access | Times Cited: 3
The Role of Therapeutic Drug Monitoring in Children
Alexander Nasr, Phillip Minar
Gastroenterology Clinics of North America (2023) Vol. 52, Iss. 3, pp. 549-563
Open Access | Times Cited: 2
Alexander Nasr, Phillip Minar
Gastroenterology Clinics of North America (2023) Vol. 52, Iss. 3, pp. 549-563
Open Access | Times Cited: 2
Choosing the Right Therapy at the Right Time for Pediatric Inflammatory Bowel Disease
Elizabeth Spencer
Gastroenterology Clinics of North America (2023) Vol. 52, Iss. 3, pp. 517-534
Closed Access | Times Cited: 1
Elizabeth Spencer
Gastroenterology Clinics of North America (2023) Vol. 52, Iss. 3, pp. 517-534
Closed Access | Times Cited: 1
Does HLA‐DQA1*05 carriage have a greater impact on the outcome of infliximab therapy for isolated small‐bowel Crohn's disease?
Juan Wu, Nannan Zhu, Jing Hu, et al.
International Journal of Immunogenetics (2024) Vol. 51, Iss. 6, pp. 380-387
Closed Access
Juan Wu, Nannan Zhu, Jing Hu, et al.
International Journal of Immunogenetics (2024) Vol. 51, Iss. 6, pp. 380-387
Closed Access
Real-World Experience Of The Association of HLADQA1*05 Allele with Loss of Response to Anti-TNF Inhibitors
Aastha Chokshi, Christina Raker, Sean Fine
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 4
Open Access
Aastha Chokshi, Christina Raker, Sean Fine
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 4
Open Access
68 - PAPEL DEL HLA DQA1*05 EN LA RESPUESTA A TRATAMIENTO BIOLÓGICO CON ANTI-TNF EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL
Andrea Pascual Oliver, Camila Cuaran Cetina, Diego Casas Deza, et al.
Gastroenterología y Hepatología (2023) Vol. 46, pp. S100-S100
Open Access
Andrea Pascual Oliver, Camila Cuaran Cetina, Diego Casas Deza, et al.
Gastroenterología y Hepatología (2023) Vol. 46, pp. S100-S100
Open Access
Prediction of disease progression and treatment success
Raja Atreya
Deleted Journal (2023) Vol. 18, Iss. 6, pp. 440-447
Closed Access
Raja Atreya
Deleted Journal (2023) Vol. 18, Iss. 6, pp. 440-447
Closed Access
Failure to Achieve Target Drug Concentrations During Induction and Not HLADQA1∗05 Carriage Is Associated With Antidrug Antibody Formation in Patients With Inflammatory Bowel Disease: Is HLADQA1∗05 Gone Before It’s Here?
Aze Wilson, Richard B. Kim
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 1123-1124
Open Access
Aze Wilson, Richard B. Kim
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 1123-1124
Open Access
Reply
Elizabeth Spencer, Marla C. Dubinsky
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 1124-1125
Open Access
Elizabeth Spencer, Marla C. Dubinsky
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 1124-1125
Open Access
